Metformin vs Pembrolizumab
Metformin vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Metformin and Pembrolizumab.
Mechanism of Action
Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Metformin — 4-9 hours; Pembrolizumab — 26 days.
Chemical Properties
Molecular Formula: Metformin — C4H11N5.
Molecular Weight: Metformin — 129.1640 g/mol.
Type: Metformin — Small molecule; Pembrolizumab — Antibody.